Kolexia
Echaniz-Laguna Andoni
Neurologie
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
257 Activités
86 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies musculaires Polyneuropathies Maladie de Charcot-Marie-Tooth Maladies du motoneurone Neuropathies périphériques Sclérose latérale amyotrophique Sclérose Ataxie Myosite

Industries

LFB
13 collaboration(s)
Dernière en 2023
Sanofi
5 collaboration(s)
Dernière en 2023
argenx BV
4 collaboration(s)
Dernière en 2022
Parexel
3 collaboration(s)
Dernière en 2023

Dernières activités

OPALE: Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)
Essai Clinique (Hôpital Pitie Salpetriere)   13 décembre 2023
Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2
Essai Clinique (CHU Nice)   10 novembre 2023
Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study: From Proper Assessment to Trial Needs - IMAGiNe Study-Lyon/Bicêtre
Essai Clinique (Hospices Civils de Lyon)   09 novembre 2023
Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments.
Blood   09 novembre 2023
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment.
The Lancet. Neurology   01 novembre 2023
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Journal of neurology, neurosurgery, and psychiatry   24 octobre 2023
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis   19 octobre 2023
THERAMAG: Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders:
Essai Clinique (CHU Saint-Étienne)   13 octobre 2023
IMLIFIDASE IN PATIENTS WITH SEVERE GUILLAIN-BARRÉ SYNDROME–A PHASE II SAFETY, TOLERABILITY AND EFFICACY STUDY
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
GENETIC MODIFIERS IN HEREDITARY AND ACQUIRED TTR AMYLOIDOSIS: UPDATE ON GENOME-WIDE ASSOCIATION STUDY
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023